Neurodiagnoses Logo
Neurodiagnoses

🧠 Neurodiagnoses Clinical Research Platform

Tridimensional analysis framework for research on 22 neurodegenerative diseases, under development. Research tools for individual case review, cohort analysis, and pharmaceutical research.

Results of our research studies are reported in the manuscripts.

🧬 Disease-Agnostic Framework

Our tridimensional framework, described in a peer-reviewed publication, supports comprehensive evaluation across 22 major neurodegenerative diseases using standardized multi-axis assessment: Genetics → Biomarkers → Neuroimaging → Clinical. Each disease profile lists the biomarkers, genetic thresholds, and clinical criteria used by the research framework.

Tauopathies (4)

AD, PSP, CBD, Pick

AT(N) framework

Synucleinopathies (3)

PD, DLB, MSA

α-syn RT-QuIC

Ataxias (6)

SCA1-7, FRDA

CAG repeats

Motor Neuron (3)

ALS, SMA, PLS

NfL, TDP-43

FTD Spectrum (3)

FTD, PPA, LATE

TDP-43 pathology

Others (3)

HD, SPG4

Repeat expansions

Individual Analysis

Comprehensive single-patient analysis across all disease categories. Multi-axis evaluation with differential diagnosis.

Demographics & Clinical Assessment
Genetic Risk Assessment
Biomarker Analysis (CSF, Plasma)
Neuroimaging Integration
Differential Diagnosis (22 diseases)

Cohort Analysis

Batch processing for research cohorts. Upload multiple patients and analyze patterns across disease categories.

Batch CSV Upload
Population Statistics
Cross-Disease Comparisons
Export Results
Research Validation

Progression Modeling

Simulate disease progression trajectories and explore what-if scenarios for treatment planning and research.

Trajectory Simulation
What-If Scenarios
Treatment Impact Modeling
Risk Stratification
Longitudinal Analysis

Cases Analyzed

0

Beta Access

Unlimited

Account Status

Active

Neurodiagnoses: Causal Fusion & Dynamic Prognosis Platform

Our platform uses a Multicomponent Biomarker (MCB) system that operates through a Four-Axis Architecture for continuous trajectory modeling of neurodegeneration.

Axis 0: Context & Intervention

Modifiable factors including treatments and lifestyle. Defines "what-if" scenariosfor treatment-aware predictions.

Examples: Donepezil, Lecanemab, Physical activity, Education

Axis 1: Cause & Etiology

Static risk factors including APOE, GBA1, LRRK2, MAPT and the complete transdiagnostic genetic panel (8 genes).

Genetic panel: APOE, TREM2, GBA1, LRRK2, MAPT, SNCA, PRKN, TBK1

Axis 2: Mechanism & Biomarkers

Molecular mechanisms including ATN+ framework (Aβ, Tau, αSyn, TDP-43) with blood-brain barrier validation.

ATN+ framework: CSF/Plasma Aβ42, pTau, αSyn SAA, TDP-43, NFL, GFAP

Axis 3: Phenotype & Topography

Clinical and topographic manifestations including neuropsychology (MMSE, MoCA), neuroimaging (Midbrain/Pons Ratio, DAT-SPECT), and continuous trajectory simulation.

Modalities: MRI volumetry, PET (Amyloid, Tau, FDG), DAT-SPECT, UPDRS

Final Synthesis: MCB Vector (7 Features)

Our prognostic engine synthesizes these four axes into a Multicomponent Biomarker (MCB) Vector:1 genetic + 2 molecular + 3 topographic + 1 temporal, ensuring transdiagnostic and explainable diagnosis.

🧬 Level 0:

4 Axis-Specific Specialists

👑 Level 1:

Meta-Classifier (Stacked Generalization)

🎯 Coverage:

AD, PD, DLB, PSP, MSA, CBD, FTD

Architecture: 4-Axis Causal Fusion |Variables: 58 transdiagnostic biomarkers & clinical features

Analysis Tools

Choose the right tool for your research needs

Individual Patient Analysis

Cohort & Research Analysis

Recent Activity

Your latest analysis results

No recent activity

Start analyzing cases to see your activity here

🎉 Beta Launch - Free Unlimited Access

All features unlocked during beta phase

Unlimited case analysis
Full access to batch processing
Access to all v15 features
Early access to Studio PoC